Sinopharm Group Co (HK:1099) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sinopharm Group Co. reported a slight revenue increase of 2.65% for the quarter ending September 2024, but experienced a significant drop in operating profit by 25.05% compared to the same period last year. Despite a 9.27% increase in total assets, the net profit attributable to shareholders decreased by 10.39%, reflecting challenges in the company’s profitability.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.